New York, NY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend for 2017.  The Board of Directors has unanimously approved an annual dividend payment of $0.03 per share. This dividend will be paid on Friday, December 29, 2017 to Daxor shareholders of record on Thursday, December 21, 2017.

Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor’s single-use diagnostic kit.  For more information regarding blood volume analysis and the Daxor BVA-100, visit Daxor’s website at www.Daxor.com.

Daxor contact information:
Michael Feldschuh, President and CEO.
212-330-8505
mfeldschuh@daxor.com

John Wilkens, Chief Financial Officer.
212-330-8504
jwilkens@daxor.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.